This site is intended for healthcare professionals
News

Revance reports positive results from ASPEN-1 phase III trial of daxibotulinumtoxinA for injection in cervical dystonia.

Read time: 1 mins
Last updated:16th Oct 2020
Published:16th Oct 2020
Condition: Cervical Dystonia
Type: drug
Register free for full access to medthority.com